Results 101 to 110 of about 21,516,320 (280)

Delivery of DNA‐encoded vaccines and proteins in mice using cutaneous suction‐mediated transfection

open access: yesFEBS Open Bio, EarlyView.
Cutaneous suction‐mediated transfection in mice for delivery of DNA‐encoded vaccines and proteins. A critical limitation of DNA vaccines and other therapeutics is transfection in vivo to produce the encoded antigens or therapeutic proteins. Cutaneous suction‐based methods have demonstrated effectiveness in many animal models and have been successfully ...
Emran O. Lallow   +12 more
wiley   +1 more source

Relationship between patient dependence and direct medical-, social-, indirect-, and informal-care costs in Spain

open access: yes, 2015
Josep Darbà,1 Lisette Kaskens2 1Department of Economics, University of Barcelona, 2BCN Health Economics and Outcomes Research SL, Barcelona, Spain Objective: The objectives of this analysis were to examine how patients' dependence on others ...
Darbà J, Kaskens L
core  

Direct medical and non-medical costs of treatment per patient by type of provider (Rs. 2010).

open access: yes, 2013
Direct medical and non-medical costs of treatment per patient by type of provider (Rs. 2010).
Filip Meheus (361893)   +4 more
core   +1 more source

Cost effectiveness of seed fairs relative to direct relief distribution in Zimbabwe [PDF]

open access: yes, 2012
Seed fairs were being promoted in Zimbabwe as an alternative seed distribution approach to sustain local input markets. Using data from ICRISAT monitoring surveys of 2005–06 and records maintained by non-governmental organisations, this article reveals
Ndlovu, Patrick V.   +4 more
core   +1 more source

The Suitability of Direct Medical Costs with INA-CBG'S Claims of Outpatient Breast Cancer in Class A and B Hospitals

open access: yesJurnal Ilmu Kesehatan Masyarakat
BPJS Kesehatan noted that cancer financing claims reached IDR 3.5 trillion, ranking second after heart disease. This study aimed to determine the difference in direct medical costs with Indonesian-Case Base Groups (INA-CBGs) claims of outpatient breast ...
Diesty Anita Nugraheni   +5 more
doaj   +1 more source

From patient advocacy to patient‐driven research: Building active partnerships beginning at the bench to reach the bedside

open access: yesFEBS Open Bio, EarlyView.
Research is strongest when conducted alongside patients, not just about them. Patient research organizations help integrate patient perspectives into research priorities, study design, and scientific meetings, leading to meaningful patient outcomes and development of relevant therapies.
Jenica H. Kakadia   +9 more
wiley   +1 more source

Quantifying the direct costs of diabetic retinopathy in a mixed healthcare system: a hospital-based study from governmental and patient perspectives

open access: yesCost Effectiveness and Resource Allocation
Background Advanced diabetic retinopathy (DR), including proliferative DR and diabetic macular edema (DME), demands costly interventions like anti-VEGF therapy, laser treatment, and vitrectomy.
Rawaa M. Jabbar   +2 more
doaj   +1 more source

The economic burden of tuberculosis in Cyprus. A probabilistic cost of illness study.

open access: yesEpidemiology, Biostatistics and Public Health, 2022
Background: Tuberculosis remains a major public health problem with considerable economic burden worldwide. The aim of this study was to estimate the economic burden of tuberculosis in Cyprus during 2009.
Savvas Zannetos   +3 more
doaj  

The economic burden of musculoskeletal disease in Korea: A cross sectional study

open access: yesBMC Musculoskeletal Disorders, 2011
Background Musculoskeletal diseases are becoming increasingly important due to population aging. However, studies on the economic burden of musculoskeletal disease in Korea are scarce.
Kim Eun-Jung   +4 more
doaj   +1 more source

Using cell‐free RNA to identify B‐ and T‐cell clonality for diagnosis and monitoring of B‐ and T‐cell neoplasms

open access: yesFEBS Open Bio, EarlyView.
Using peripheral blood for determining B‐cell or T‐cell clonality is more reliable when we use cell‐free RNA (cfRNA) because cells release blood significantly more RNA than DNA. Next‐generation sequencing (NGS) of cfRNA allows us to evaluate fragment cfRNA and evaluate clonality reliably without the need for prior determination of the specific dominant
Adam Albitar   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy